Tomoki Imaoka

966 total citations
20 papers, 718 citations indexed

About

Tomoki Imaoka is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Tomoki Imaoka has authored 20 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Molecular Biology. Recurrent topics in Tomoki Imaoka's work include Drug Transport and Resistance Mechanisms (10 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Ion Transport and Channel Regulation (3 papers). Tomoki Imaoka is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), Pharmacological Effects and Toxicity Studies (5 papers) and Ion Transport and Channel Regulation (3 papers). Tomoki Imaoka collaborates with scholars based in Japan, United States and Germany. Tomoki Imaoka's co-authors include Hiroyuki Kusuhara, Yuichi Sugiyama, Kenji Takeuchi, Masashi Adachi, John D. Schuetz, Hitoshi Endou, Eiichi Fuse, Harunobu Tahara, Hermann Koepsell and Noriko Okudaira and has published in prestigious journals such as Scientific Reports, Journal of the American Society of Nephrology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Tomoki Imaoka

20 papers receiving 702 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tomoki Imaoka Japan	14	385	248	139	133	133	20	718
Vikram Arya United States	18	479 1.2×	359 1.4×	134 1.0×	177 1.3×	280 2.1×	50	1.1k
Masanori Horinouchi Japan	14	776 2.0×	512 2.1×	160 1.2×	202 1.5×	209 1.6×	16	1.1k
Sarah Shugarts United States	9	259 0.7×	119 0.5×	76 0.5×	130 1.0×	134 1.0×	13	691
J H Lin United States	13	325 0.8×	140 0.6×	209 1.5×	146 1.1×	192 1.4×	17	769
Fumihiko Ushigome Japan	13	325 0.8×	218 0.9×	43 0.3×	152 1.1×	105 0.8×	14	662
Rucha Sane United States	14	305 0.8×	151 0.6×	124 0.9×	151 1.1×	284 2.1×	36	713
Heike Tegude Germany	8	360 0.9×	176 0.7×	185 1.3×	113 0.8×	328 2.5×	9	704
Er‐jia Wang China	11	333 0.9×	147 0.6×	112 0.8×	158 1.2×	186 1.4×	13	685
Annick Seithel Germany	6	765 2.0×	371 1.5×	132 0.9×	214 1.6×	251 1.9×	7	1.1k
Dirk Theile Germany	18	469 1.2×	188 0.8×	235 1.7×	331 2.5×	129 1.0×	61	1.1k

Countries citing papers authored by Tomoki Imaoka

Since Specialization

Citations

This map shows the geographic impact of Tomoki Imaoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoki Imaoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoki Imaoka more than expected).

Fields of papers citing papers by Tomoki Imaoka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoki Imaoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoki Imaoka. The network helps show where Tomoki Imaoka may publish in the future.

Co-authorship network of co-authors of Tomoki Imaoka

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoki Imaoka. A scholar is included among the top collaborators of Tomoki Imaoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoki Imaoka. Tomoki Imaoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taniguchi, Toru, Isao Yasumatsu, Hiroaki Inagaki, et al.. (2024). Optimization of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors, Leading to the Potent DS08701581. ACS Medicinal Chemistry Letters. 15(7). 1010–1016. 1 indexed citations

Imaoka, Tomoki, Hiroshi Kimura, Kengo Watanabe, et al.. (2024). Development of a novel gut microphysiological system that facilitates assessment of drug absorption kinetics in gut. Scientific Reports. 14(1). 29921–29921. 6 indexed citations

Watanabe, Kengo, et al.. (2023). Recent Advances in the Gastrointestinal Complex in Vitro Model for ADME Studies. Pharmaceutics. 16(1). 37–37. 5 indexed citations

Imaoka, Tomoki, Weize Huang, Sara Shum, et al.. (2021). Bridging the gap between in silico and in vivo by modeling opioid disposition in a kidney proximal tubule microphysiological system. Scientific Reports. 11(1). 21356–21356. 21 indexed citations

Imaoka, Tomoki, et al.. (2021). Gutsy science: In vitro systems of the human intestine to model oral drug disposition. Pharmacology & Therapeutics. 230. 107962–107962. 18 indexed citations

Imaoka, Tomoki, Lu Wang, Matthew G. McDonald, et al.. (2020). Microphysiological system modeling of ochratoxin A-associated nephrotoxicity. Toxicology. 444. 152582–152582. 26 indexed citations

Chapron, Alenka, Brian D. Chapron, Dale W. Hailey, et al.. (2020). An Improved Vascularized, Dual-Channel Microphysiological System Facilitates Modeling of Proximal Tubular Solute Secretion. ACS Pharmacology & Translational Science. 3(3). 496–508. 23 indexed citations

Taniguchi, Toru, Hiroaki Inagaki, Daichi Baba, et al.. (2019). Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity. ACS Medicinal Chemistry Letters. 10(5). 737–742. 19 indexed citations

Matsunaga, Hironori, Makoto Nakagawa, Masayuki Yamaguchi, et al.. (2019). Characterization of a novel BBB-permeable mutant IDH1 inhibitor, DS-1001b. Annals of Oncology. 30. v145–v146. 2 indexed citations

10.

Karibe, Tsuyoshi, Tomoki Imaoka, Kōji Abe, & Osamu Ando. (2018). Curcumin as an In Vivo Selective Intestinal Breast Cancer Resistance Protein Inhibitor in Cynomolgus Monkeys. Drug Metabolism and Disposition. 46(5). 667–679. 21 indexed citations

11.

Mikkaichi, Tsuyoshi, Daisuke Nakai, Yasushi Yoshigae, et al.. (2015). Liver-selective distribution in rats supports the importance of active uptake into the liver via organic anion transporting polypeptides (OATPs) in humans. Drug Metabolism and Pharmacokinetics. 30(5). 334–340. 9 indexed citations

12.

Mikkaichi, Tsuyoshi, Yasushi Yoshigae, Hiroshi Masumoto, et al.. (2014). Edoxaban Transport via P-Glycoprotein Is a Key Factor for the Drug’s Disposition. Drug Metabolism and Disposition. 42(4). 520–528. 78 indexed citations

13.

Karibe, Tsuyoshi, Kōji Abe, Tomoki Imaoka, et al.. (2014). Evaluation of the Usefulness of Breast Cancer Resistance Protein (BCRP) Knockout Mice and BCRP Inhibitor-Treated Monkeys to Estimate the Clinical Impact of BCRP Modulation on the Pharmacokinetics of BCRP Substrates. Pharmaceutical Research. 32(5). 1634–1647. 25 indexed citations

14.

Imaoka, Tomoki, Tsuyoshi Mikkaichi, Kōji Abe, et al.. (2013). Integrated Approach of In Vivo and In Vitro Evaluation of the Involvement of Hepatic Uptake Organic Anion Transporters in the Drug Disposition in Rats Using Rifampicin as an Inhibitor. Drug Metabolism and Disposition. 41(7). 1442–1449. 18 indexed citations

15.

Imaoka, Tomoki, Hiroyuki Kusuhara, Masashi Adachi, et al.. (2006). Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir. Molecular Pharmacology. 71(2). 619–627. 221 indexed citations

16.

Tahara, Harunobu, Hiroyuki Kusuhara, Hitoshi Endou, et al.. (2005). A Species Difference in the Transport Activities of H2 Receptor Antagonists by Rat and Human Renal Organic Anion and Cation Transporters. Journal of Pharmacology and Experimental Therapeutics. 315(1). 337–345. 137 indexed citations

17.

Nagata, Yoshinori, Hiroyuki Kusuhara, Tomoki Imaoka, Hitoshi Endou, & Yuichi Sugiyama. (2004). Involvement of Rat Organic Anion Transporter 3 in the Uptake of an Organic Herbicide, 2,4-Dichlorophenoxyacetate, by the isOlated Rat Choroid Plexus. Journal of Pharmaceutical Sciences. 93(11). 2724–2732. 15 indexed citations

18.

Imaoka, Tomoki, Hiroyuki Kusuhara, Satomi Adachi‐Akahane, et al.. (2004). The Renal-Specific Transporter Mediates Facilitative Transport of Organic Anions at the Brush Border Membrane of Mouse Renal Tubules. Journal of the American Society of Nephrology. 15(8). 2012–2022. 47 indexed citations

19.

Matsuzaki, Katsumi, Tomoki Imaoka, Makoto Asano, & Kumiko Miyajima. (1993). Development of a Model Membrane System Using Stratum Corneum Lipids for Estimation of Drug Skin Permeability.. Chemical and Pharmaceutical Bulletin. 41(3). 575–579. 21 indexed citations

20.

Shirasaka, Tetsuhiko, M Fukushima, Yuji Shimamoto, et al.. (1990). [Metabolic characteristics and antitumor activity of BOF-A2, a new 5-fluorouracil derivative].. PubMed. 17(5). 1051–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact